This document provides information about the "Pharma Compliance Europe" conference taking place on October 7-8, 2015 in London. The conference will bring together senior compliance executives from pharmaceutical companies to discuss challenges in compliance, transparency, and managing relationships with healthcare professionals. It will include keynote speeches, panels, roundtable discussions, and an exhibition on topics such as developing global compliance programs, data privacy laws, monitoring practices, and culture of integrity. The event aims to help compliance professionals benchmark their strategies and programs against industry best practices.
Pharma Maintenance2Reliability minds 2013 - MAIN PRMaria Willamowius
One of Europe´s most important conferences for strategic approaches and challenges in the field of plant asset- maintenance and reliability management in the Pharma & Life Science industries More information regarding speakers, keynotes, main topics and program on : http://pharma-maintenance2013.we-conect.com/
This document provides an agenda and information for the Partnerships in Clinical Trials conference taking place November 17-19, 2015 in Hamburg, Germany. The conference will focus on key topics in clinical trials including risk-based monitoring, patient centricity, innovation, and partnerships. It outlines the schedule, speakers, and session topics over the three days. Some highlights include workshops on outsourcing strategies, leadership, and risk-based monitoring on November 17th, and keynotes on the evolving partnership landscape, TransCelerate progress, and a patient perspective on November 18-19th. The agenda provides details on over 120 speakers and 8 streams of concurrent sessions on issues important to the clinical trials industry.
This document provides information on the "Discovering the Route to Regulatory Compliance" conference taking place on September 23-24, 2015 in Barcelona, Spain. The conference will address topics related to regulatory compliance with REACH, including preparing for the 2018 registration deadline, managing substances of very high concern (SVHCs) and applications for authorization, substance and dossier evaluation, safety data sheets, and more. It lists keynote speakers from the European Chemicals Agency and industry organizations discussing these topics.
London global transparency pc15105 brochureMarket iT
This document provides information about the "5th Annual Global Transparency Reporting Congress" conference that will take place on April 15-16, 2015 in London. The conference will focus on evolving guidelines for disclosing healthcare professional spending across the globe. It will include sessions on best practices for implementing transparency codes and managing relationships with healthcare professionals. Representatives from EFPIA, ABPI, various pharmaceutical companies, and medical organizations are scheduled to present.
Anticorruption, data protection, confidential information and intellectual property rights, patient safety, competition and antitrust law, sales and marketing ethics - all among the issues presented here are at the forefront of legal challenges faced by international law firms in the healthcare sector, around the world.
Is Pharmacy for you?
Check it out!
Want to Help People Get Well?
Like to Work Directly with Patients?
Enjoy a Wide Variety of Career Opportunities?
Want to be an Important Member of the Healthcare Team?
Excited to be a Part of Major Innovations in Drug Therapy?
Want to have a Job Mobility, Stability, and Flexibility?
If you want to be an instrumental character in improving patients' health by choosing the right medicines, then, this career is for you!
Have fun :)
Top 10 compliance interview questions and answersLadyGaGa234
The document provides resources for compliance interviews, including common interview questions, tips for answering questions, and links to additional reference materials. Some key points covered are sample questions about experience in compliance fields, challenges the position may present, describing a typical work week, discussing weaknesses, and explaining why the company should hire the candidate. The document aims to help candidates prepare for different types of compliance interviews.
Pharma Maintenance2Reliability minds 2013 - MAIN PRMaria Willamowius
One of Europe´s most important conferences for strategic approaches and challenges in the field of plant asset- maintenance and reliability management in the Pharma & Life Science industries More information regarding speakers, keynotes, main topics and program on : http://pharma-maintenance2013.we-conect.com/
This document provides an agenda and information for the Partnerships in Clinical Trials conference taking place November 17-19, 2015 in Hamburg, Germany. The conference will focus on key topics in clinical trials including risk-based monitoring, patient centricity, innovation, and partnerships. It outlines the schedule, speakers, and session topics over the three days. Some highlights include workshops on outsourcing strategies, leadership, and risk-based monitoring on November 17th, and keynotes on the evolving partnership landscape, TransCelerate progress, and a patient perspective on November 18-19th. The agenda provides details on over 120 speakers and 8 streams of concurrent sessions on issues important to the clinical trials industry.
This document provides information on the "Discovering the Route to Regulatory Compliance" conference taking place on September 23-24, 2015 in Barcelona, Spain. The conference will address topics related to regulatory compliance with REACH, including preparing for the 2018 registration deadline, managing substances of very high concern (SVHCs) and applications for authorization, substance and dossier evaluation, safety data sheets, and more. It lists keynote speakers from the European Chemicals Agency and industry organizations discussing these topics.
London global transparency pc15105 brochureMarket iT
This document provides information about the "5th Annual Global Transparency Reporting Congress" conference that will take place on April 15-16, 2015 in London. The conference will focus on evolving guidelines for disclosing healthcare professional spending across the globe. It will include sessions on best practices for implementing transparency codes and managing relationships with healthcare professionals. Representatives from EFPIA, ABPI, various pharmaceutical companies, and medical organizations are scheduled to present.
Anticorruption, data protection, confidential information and intellectual property rights, patient safety, competition and antitrust law, sales and marketing ethics - all among the issues presented here are at the forefront of legal challenges faced by international law firms in the healthcare sector, around the world.
Is Pharmacy for you?
Check it out!
Want to Help People Get Well?
Like to Work Directly with Patients?
Enjoy a Wide Variety of Career Opportunities?
Want to be an Important Member of the Healthcare Team?
Excited to be a Part of Major Innovations in Drug Therapy?
Want to have a Job Mobility, Stability, and Flexibility?
If you want to be an instrumental character in improving patients' health by choosing the right medicines, then, this career is for you!
Have fun :)
Top 10 compliance interview questions and answersLadyGaGa234
The document provides resources for compliance interviews, including common interview questions, tips for answering questions, and links to additional reference materials. Some key points covered are sample questions about experience in compliance fields, challenges the position may present, describing a typical work week, discussing weaknesses, and explaining why the company should hire the candidate. The document aims to help candidates prepare for different types of compliance interviews.
3rd corporate compliance & transparency in pharmaMarket iT
This document summarizes a conference on corporate compliance and transparency in the pharmaceutical industry to be held in Zurich, Switzerland on February 25-26, 2015. The conference will address topics such as EFPIA disclosure requirements, defining transparency frameworks, preventing corruption, and challenges in emerging markets. It will feature speakers from pharmaceutical companies and industry groups. Attendees will include compliance officers, lawyers, and those involved in corporate responsibility, contracts, auditing, and business conduct.
Corporate Compliance & Transparency in the Pharmaceutical IndustryMarket iT
This document provides information about the 4th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry conference taking place on February 24-25, 2016 in Zurich. The conference will focus on key issues relating to compliance, disclosure, and transparency in the pharmaceutical industry. It will include an on-stage interview with EFPIA, presentations on implementing disclosure codes and lessons learned, and panels on defining fair market value and optimizing HCP interactions transparently. The event aims to help participants learn how to address compliance challenges, develop consistent transparency strategies, and establish effective investigation procedures.
IDMP Implementation - Impact on Data, Systems and Processes. How to cover gap...Torben Haagh
ISO IDMP will be mandatory from July 1st 2016 and it will make a fundamental impact on the way the pharmaceutical industry is required to collect, manage and submit relevant data. Now is the last call for all marketing authorisation holders to (re)think their data submission policies and processes to make sure you close your IDMP implementation gaps in the next 12 month and have a clear vision of the next challenges lying ahead!
Don’t miss out on the opportunity to get your questions answered, to benchmark the stage of your preparation, to initiate partnerships and to take an active part in designing the RIM’s community future agenda! Join us this summer in Berlin and gain valuable, practical information:
# Learn how to assess and analyse data requirements for the IDMP standards by discussing possible interpretations with our expert from regulatory bodies on-site!
# Benchmark your own IDPM Implementation process with peers from both big and mid-size pharma
# Share insights how the IDMP standards are changing the interactions between IT-Systems, company departments, contract manufacturers and regulatory agencies
# Discuss and compare with your peers experiences with vendors and solution providers offering help to achieve your IDMP implementation goals!
For more information visit our website: http://bit.ly/EventWebsite
If you would like to be part of the conference, you can register now here: http://bit.ly/Register-Event
SMi Group's Injectable Drug Delivery 2019 conferenceDale Butler
The document advertises the 2nd Annual Injectable Drug Delivery conference taking place May 14-16, 2019 in London. The conference will focus on innovations in injectable drug formulations and devices, with sessions on formulation development, device design, manufacturing, and regulatory issues. Speakers will discuss challenges and solutions for protein formulations, digital health technologies, long-acting injectables, pre-filled syringes and more. A pre-conference workshop on use-related risk analysis in product development will also be held. Attendees can register online or by phone.
This document is a program for the CBI Global Compliance Congress taking place November 18-19, 2015 in Munich, Germany. The program features panels and presentations on various topics related to compliance best practices from industry and government perspectives. Speakers include representatives from EFPIA, IFPMA, Transparency International, various pharmaceutical companies, and regulatory bodies such as the Serious Fraud Office. Breakout sessions will address issues like HCP relationships, third party oversight, transparency reporting, and challenges for small/mid-size compliance programs. An invitation-only CCO Summit is also included on both days.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today! Learn more here.
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Want to know more regarding this topic area? Then join us at our
IDMP Implementation - Impact on Data, Systems and Processes
24 – 25 June 2015 | Steigenberger Hotel Berlin, Germany
For more information take a look at our agenda here: http://bit.ly/IDMP_agenda
Or visit our website: http://bit.ly/IDMP_website
Food&Beverage Innovation Forum 2014 14th-16th May
Chateau Star River Pudong, Shanghai, China
The world is moving fast, we need to go even faster.
Key Words: Internet of Things Food Safety Traceability Early Warning Platform Supply Chain Visibility Food Safety Risk
Nutrition Chinese Food Culture Product Lifecycle Management
3D Printing Food Digital Marketing Customer Engagement
Made to Order
SMi Group's Injectable Drug Delivery 2018 conferenceDale Butler
This document provides information about two half-day pre-conference workshops on injectable drug delivery taking place on May 15, 2018 in London. Workshop A from 8:30-12:30 will focus on creating a human factors and usability engineering file in accordance with FDA and IEC62366-1 standards. Workshop B from 13:30-17:30 will examine wearable injectors and their ability to meet clinical needs while reducing healthcare costs. Both workshops aim to equip attendees with practical knowledge and strategies for developing safer and more user-friendly drug delivery devices and technologies.
This document announces a conference on evolving guidelines for disclosing healthcare professional spending across Europe. The 6th Annual Global Transparency Reporting Congress will be held on April 7-8, 2016 in Frankfurt, Germany and will feature presentations from transparency reporting professionals from various pharmaceutical companies and industry associations. The conference will provide insights on implementing disclosure guidelines and managing compliance risks related to healthcare professional payments.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
This document advertises an international conference on implementing the IDMP standards for pharmaceutical data. The conference will be held in Berlin in June 2015 and will provide opportunities to:
1) Learn how to assess data requirements and analyze interpretations of the IDMP standards from experts;
2) Benchmark your organization's IDMP implementation process with peers from large and mid-size pharmaceutical companies; and
3) Share insights on how the IDMP standards are changing interactions between IT systems, company functions, and regulatory agencies.
Interactive workshops and case studies from major pharmaceutical companies will also be provided. The conference aims to help companies understand, prioritize, and implement strategies to achieve seamless and fully compliant regulatory information management under the new ID
Meet GE Healthcare, Pfizer, Novartis Pharma, Boehringer-Ingelheim Pharma and ...Torben Haagh
The leading European conference on the topic of IDMP Implementation - Impact on Data, Systems and Processes is due to take place in Berlin from 24 – 25 June 2015. Don't miss your chance to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
There are now limited places available, so make sure you secure your conference ticket today! Learn more here:
http://bit.ly/_Agenda-
This document provides information about a digital transformation conference for the pharmaceutical industry to be held in Copenhagen on April 13-14, 2016. The conference aims to share digital initiatives for patients and healthcare professionals and discuss how organizations can better utilize online opportunities. It will feature keynote speakers from companies like LEO Innovation Lab and Google discussing how digital technologies are changing pharma business models and engagement. The agenda also includes sessions on using social media, real-world evidence, direct-to-consumer communication, and enhancing customer experiences through data-driven insights. The conference seeks to inspire participants to embrace new digital channels and approaches to collaborating with customers.
World ADC Frankfurt 2015 - sample brochureWorld ADC
The World ADC Frankfurt meeting has been established with the simple mission of speeding up the development of more potent and safe antibody drug conjugates.
Learn not only how to make an ADC, but how to make a great one. With insights on numerous novel payload technologies, robust strategies for preclinical evaluation and emerging clinical data, there is no better opportunity to accelerate your research.
This document provides information about a clinical quality and compliance masterclass conference taking place on June 16th and 17th, 2016 in Vienna. The conference will focus on managing clinical quality for greater compliance, effectiveness, and audit readiness. Over the two days, there will be keynote speakers from major pharmaceutical companies, case studies, and workshops on topics such as on-site quality improvements, inspection readiness, quality risk management, and third-party oversight. Attendees will include quality assurance professionals from pharmaceutical and biotech companies as well as CROs.
The document provides information about the 9th Pharmacovigilance Conference to be held on September 2nd, 2015 in Mumbai, India. It discusses key themes that will be covered including legislation, audits, signal detection, patient safety, and the developing regulatory framework. It outlines the agenda with topics such as PV for biologics, challenges in PV lifecycle management, and the necessary shift of sponsors and CROs from adversaries to partners. The conference aims to bring together representatives from the pharmaceutical industry and regulatory bodies to address issues in pharmacovigilance and risk management. It is intended to help attendees expand their knowledge and network with industry leaders.
4th annual Pharma Anti-Counterfeiting 2015Dinesh T
4th Annual Pharma Anti-Counterfeiting 2015 taking place on 08th & 09th September 2015, London, UK
Please contact me :-Dinesh:- dinesh@virtueinsight.co.in
This document provides information about an upcoming conference on orphan drugs that will take place on October 18-20, 2016 in London. It includes details about the interactive workshops on the first day and key sessions over the two main conference days that will discuss topics such as regulatory challenges, developing treatments for rare diseases, pediatric orphan drug development, and partnerships in the orphan drug field. Information is provided on registering for the event and sponsorship opportunities.
Pharma IQ brings you Clinical Trial Supply Europe Conference Profit. Successfully cutting costs and overages whilst increasing the flexibility and reactivity of your clinical supply network to support global clinical trials.
SMi Group's Inaugural Big Data in Pharma conferenceDale Butler
This document provides information about a conference on big data in the pharmaceutical industry, including an agenda, speaker details, and workshop information. The two-day conference will focus on how big data can be leveraged to enhance research and development, clinical trials, and real-world evidence generation. Highlights include sessions on personalized medicine, predictive analytics, and social media strategies. Post-conference workshops will discuss the legal aspects of cloud computing and designing studies using big data to support drug development and marketing. The event aims to help pharmaceutical companies exploit big data's potential to create better medicines and new revenue streams.
3rd corporate compliance & transparency in pharmaMarket iT
This document summarizes a conference on corporate compliance and transparency in the pharmaceutical industry to be held in Zurich, Switzerland on February 25-26, 2015. The conference will address topics such as EFPIA disclosure requirements, defining transparency frameworks, preventing corruption, and challenges in emerging markets. It will feature speakers from pharmaceutical companies and industry groups. Attendees will include compliance officers, lawyers, and those involved in corporate responsibility, contracts, auditing, and business conduct.
Corporate Compliance & Transparency in the Pharmaceutical IndustryMarket iT
This document provides information about the 4th Annual Corporate Compliance & Transparency in the Pharmaceutical Industry conference taking place on February 24-25, 2016 in Zurich. The conference will focus on key issues relating to compliance, disclosure, and transparency in the pharmaceutical industry. It will include an on-stage interview with EFPIA, presentations on implementing disclosure codes and lessons learned, and panels on defining fair market value and optimizing HCP interactions transparently. The event aims to help participants learn how to address compliance challenges, develop consistent transparency strategies, and establish effective investigation procedures.
IDMP Implementation - Impact on Data, Systems and Processes. How to cover gap...Torben Haagh
ISO IDMP will be mandatory from July 1st 2016 and it will make a fundamental impact on the way the pharmaceutical industry is required to collect, manage and submit relevant data. Now is the last call for all marketing authorisation holders to (re)think their data submission policies and processes to make sure you close your IDMP implementation gaps in the next 12 month and have a clear vision of the next challenges lying ahead!
Don’t miss out on the opportunity to get your questions answered, to benchmark the stage of your preparation, to initiate partnerships and to take an active part in designing the RIM’s community future agenda! Join us this summer in Berlin and gain valuable, practical information:
# Learn how to assess and analyse data requirements for the IDMP standards by discussing possible interpretations with our expert from regulatory bodies on-site!
# Benchmark your own IDPM Implementation process with peers from both big and mid-size pharma
# Share insights how the IDMP standards are changing the interactions between IT-Systems, company departments, contract manufacturers and regulatory agencies
# Discuss and compare with your peers experiences with vendors and solution providers offering help to achieve your IDMP implementation goals!
For more information visit our website: http://bit.ly/EventWebsite
If you would like to be part of the conference, you can register now here: http://bit.ly/Register-Event
SMi Group's Injectable Drug Delivery 2019 conferenceDale Butler
The document advertises the 2nd Annual Injectable Drug Delivery conference taking place May 14-16, 2019 in London. The conference will focus on innovations in injectable drug formulations and devices, with sessions on formulation development, device design, manufacturing, and regulatory issues. Speakers will discuss challenges and solutions for protein formulations, digital health technologies, long-acting injectables, pre-filled syringes and more. A pre-conference workshop on use-related risk analysis in product development will also be held. Attendees can register online or by phone.
This document is a program for the CBI Global Compliance Congress taking place November 18-19, 2015 in Munich, Germany. The program features panels and presentations on various topics related to compliance best practices from industry and government perspectives. Speakers include representatives from EFPIA, IFPMA, Transparency International, various pharmaceutical companies, and regulatory bodies such as the Serious Fraud Office. Breakout sessions will address issues like HCP relationships, third party oversight, transparency reporting, and challenges for small/mid-size compliance programs. An invitation-only CCO Summit is also included on both days.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today! Learn more here.
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Want to know more regarding this topic area? Then join us at our
IDMP Implementation - Impact on Data, Systems and Processes
24 – 25 June 2015 | Steigenberger Hotel Berlin, Germany
For more information take a look at our agenda here: http://bit.ly/IDMP_agenda
Or visit our website: http://bit.ly/IDMP_website
Food&Beverage Innovation Forum 2014 14th-16th May
Chateau Star River Pudong, Shanghai, China
The world is moving fast, we need to go even faster.
Key Words: Internet of Things Food Safety Traceability Early Warning Platform Supply Chain Visibility Food Safety Risk
Nutrition Chinese Food Culture Product Lifecycle Management
3D Printing Food Digital Marketing Customer Engagement
Made to Order
SMi Group's Injectable Drug Delivery 2018 conferenceDale Butler
This document provides information about two half-day pre-conference workshops on injectable drug delivery taking place on May 15, 2018 in London. Workshop A from 8:30-12:30 will focus on creating a human factors and usability engineering file in accordance with FDA and IEC62366-1 standards. Workshop B from 13:30-17:30 will examine wearable injectors and their ability to meet clinical needs while reducing healthcare costs. Both workshops aim to equip attendees with practical knowledge and strategies for developing safer and more user-friendly drug delivery devices and technologies.
This document announces a conference on evolving guidelines for disclosing healthcare professional spending across Europe. The 6th Annual Global Transparency Reporting Congress will be held on April 7-8, 2016 in Frankfurt, Germany and will feature presentations from transparency reporting professionals from various pharmaceutical companies and industry associations. The conference will provide insights on implementing disclosure guidelines and managing compliance risks related to healthcare professional payments.
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
This document advertises an international conference on implementing the IDMP standards for pharmaceutical data. The conference will be held in Berlin in June 2015 and will provide opportunities to:
1) Learn how to assess data requirements and analyze interpretations of the IDMP standards from experts;
2) Benchmark your organization's IDMP implementation process with peers from large and mid-size pharmaceutical companies; and
3) Share insights on how the IDMP standards are changing interactions between IT systems, company functions, and regulatory agencies.
Interactive workshops and case studies from major pharmaceutical companies will also be provided. The conference aims to help companies understand, prioritize, and implement strategies to achieve seamless and fully compliant regulatory information management under the new ID
Meet GE Healthcare, Pfizer, Novartis Pharma, Boehringer-Ingelheim Pharma and ...Torben Haagh
The leading European conference on the topic of IDMP Implementation - Impact on Data, Systems and Processes is due to take place in Berlin from 24 – 25 June 2015. Don't miss your chance to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
There are now limited places available, so make sure you secure your conference ticket today! Learn more here:
http://bit.ly/_Agenda-
This document provides information about a digital transformation conference for the pharmaceutical industry to be held in Copenhagen on April 13-14, 2016. The conference aims to share digital initiatives for patients and healthcare professionals and discuss how organizations can better utilize online opportunities. It will feature keynote speakers from companies like LEO Innovation Lab and Google discussing how digital technologies are changing pharma business models and engagement. The agenda also includes sessions on using social media, real-world evidence, direct-to-consumer communication, and enhancing customer experiences through data-driven insights. The conference seeks to inspire participants to embrace new digital channels and approaches to collaborating with customers.
World ADC Frankfurt 2015 - sample brochureWorld ADC
The World ADC Frankfurt meeting has been established with the simple mission of speeding up the development of more potent and safe antibody drug conjugates.
Learn not only how to make an ADC, but how to make a great one. With insights on numerous novel payload technologies, robust strategies for preclinical evaluation and emerging clinical data, there is no better opportunity to accelerate your research.
This document provides information about a clinical quality and compliance masterclass conference taking place on June 16th and 17th, 2016 in Vienna. The conference will focus on managing clinical quality for greater compliance, effectiveness, and audit readiness. Over the two days, there will be keynote speakers from major pharmaceutical companies, case studies, and workshops on topics such as on-site quality improvements, inspection readiness, quality risk management, and third-party oversight. Attendees will include quality assurance professionals from pharmaceutical and biotech companies as well as CROs.
The document provides information about the 9th Pharmacovigilance Conference to be held on September 2nd, 2015 in Mumbai, India. It discusses key themes that will be covered including legislation, audits, signal detection, patient safety, and the developing regulatory framework. It outlines the agenda with topics such as PV for biologics, challenges in PV lifecycle management, and the necessary shift of sponsors and CROs from adversaries to partners. The conference aims to bring together representatives from the pharmaceutical industry and regulatory bodies to address issues in pharmacovigilance and risk management. It is intended to help attendees expand their knowledge and network with industry leaders.
4th annual Pharma Anti-Counterfeiting 2015Dinesh T
4th Annual Pharma Anti-Counterfeiting 2015 taking place on 08th & 09th September 2015, London, UK
Please contact me :-Dinesh:- dinesh@virtueinsight.co.in
This document provides information about an upcoming conference on orphan drugs that will take place on October 18-20, 2016 in London. It includes details about the interactive workshops on the first day and key sessions over the two main conference days that will discuss topics such as regulatory challenges, developing treatments for rare diseases, pediatric orphan drug development, and partnerships in the orphan drug field. Information is provided on registering for the event and sponsorship opportunities.
Pharma IQ brings you Clinical Trial Supply Europe Conference Profit. Successfully cutting costs and overages whilst increasing the flexibility and reactivity of your clinical supply network to support global clinical trials.
SMi Group's Inaugural Big Data in Pharma conferenceDale Butler
This document provides information about a conference on big data in the pharmaceutical industry, including an agenda, speaker details, and workshop information. The two-day conference will focus on how big data can be leveraged to enhance research and development, clinical trials, and real-world evidence generation. Highlights include sessions on personalized medicine, predictive analytics, and social media strategies. Post-conference workshops will discuss the legal aspects of cloud computing and designing studies using big data to support drug development and marketing. The event aims to help pharmaceutical companies exploit big data's potential to create better medicines and new revenue streams.
TRansparency International : 2018 guide for whistleblowing legislationMarket iT
This document provides guidance on best practices for whistleblowing legislation. It discusses the importance of whistleblowers in exposing wrongdoing that threatens public interests. It notes that whistleblowers often face retaliation, so legislation needs to protect them from unfair treatment. The document then outlines recommendations and international principles for effective whistleblower protection laws.
This document provides guidelines on consent under the General Data Protection Regulation (GDPR). It discusses the key elements of valid consent including being freely given, specific, informed, and requiring an unambiguous indication of wishes. It also covers topics like demonstrating consent, withdrawing consent, interactions with other lawful grounds for processing, and specific areas like children's consent and scientific research. The guidelines are intended to help organizations comply with consent requirements under the GDPR.
MedTech europe code of ethical business practiceMarket iT
The MedTech Europe Code of Ethical Business Practice outlines rules for industry support of healthcare professionals and organizations. It establishes criteria for educational events and prohibits direct sponsorship of individual HCP attendance, instead requiring support through educational grants to medical societies or hospitals. The Conference Vetting System will review events for compliance with these criteria and issue decisions on whether companies can provide support.
Cybersecurity risks to medical devices and healthcare systems have increased due to greater connectivity of devices, software use, and data sharing. Recent incidents highlight vulnerabilities that could disrupt care, compromise data, or directly endanger patients if devices are attacked. Regulators and industry stakeholders must collaborate to address both security and safety issues through coordinated risk management and standards application over medical device lifecycles.
The document is a press release from PatientView announcing the findings of their 2016 survey on the corporate reputation of pharmaceutical companies from the patient perspective. Some key findings:
- Patient groups' perception of the pharmaceutical industry's reputation fell in 2016 after reaching a high in 2015. Only 38% of groups viewed it as excellent/good compared to 45% in 2015.
- Patient groups were more skeptical in 2016 of the industry's ability to innovate and conduct other important activities. New Zealand groups had the least confidence in innovation.
- Groups proposed a 14-point plan for companies to improve patient centricity, prioritizing transparency and patient involvement.
- ViiV Healthcare ranked first in
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
1. 7-8 October 2015
The Guoman Tower Hotel, London
Sponsors:
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
BOOK
NOW
&
SAVE
COMPLIANCE STRATEGY
FOR PHARMA
2. Very interesting sessions,
topics tackled of great
interest, and perfect
organisation.”
Manager | Life Sciences & Health Care Deloitte
“ Very meaningful agenda
and diverse speakers.
Great content.”
OEC Director - International Operations | Abbvie
Pharmaceuticals
“
ABOUT THE EVENT
We have worked with the pharmaceutical compliance community
for the past 3 years. There has been progression over the years as
compliance programmes mature and focus changes for compliance
professionals.
Low public confidence in how pharma conducts relationships and
lack of transparency has meant governments have implemented a raft
of reforms that have impacted compliance. Over the past year, with
the implementation of EFPIA guidelines, there has been more and
more discussion in the conference room, and in research about the
challenges faced. We tailor the programme year after year to address
the most pressing and emerging topics of highest relevance to the
industry at that time.
The 3rd
annual Pharma Compliance Europe will unite senior
compliance executives to share their experiences and explore these
challenges. This is your opportunity to engage and benchmark your
compliance programme and hear the latest operational best practices,
transparency and disclosure review and due diligence and monitoring
considerations. 2015 promises to be the biggest ever. Join us to learn
how to future proof your compliance programme.
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
3. IT’S ALL ABOUT YOU EVENT AT A GLANCE
This is the leading compliance and multichannel marketing event
Europe has to offer in 2015! No matter where your interest lies, we have
content, networking and potential partners for you.
By bringing two events together under one roof, you get to choose the
sessions which are the most applicable to your business and network
with more of your industry peers.
121 PARTNERING
KEYNOTES
ROUNDTABLES
EXPERT PANELS
EXHIBITION
NETWORKING
DRINKS PARTY
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
Pharma Compliance Europe shares the latest best practices
and methods to mitigate risk allowing you to tackle compliance
stumbling blocks head on.
It is more than just another conference. It is fresh, innovative and
genuinely engages the audience – and pretty fun! This year’s
event builds on these successes, covering the latest operational
best practices, transparency and disclosure review and due
diligence and monitoring considerations.
DigiPharm Europe discusses the vast opportunities that digital
and mobile technologies offer in patient engagement and
marketing strategies. It is about presenting the right message as
part of a well-considered, multichannel marketing effort, and how
to utilise the different channels to create a valuable experience
for the customer.
4. Dr. Erik Eglite
Vice President, Chief Compliance Officer &
Corporate Counsel
Lundbeck
Managing compliance risks in a global market
by driving better practices, ownership and
accountability
Dr. Christoph C. Dengler
Vice President Legal
Stada
Accountability and risk of the
compliance officer himself
Nick Tyler
Senior Director and Global Privacy Officer
Takeda Pharmaceuticals International GmbH
Navigating data privacy laws while maintaining
transparency and reporting
Elke Baumann
Global Integrity & Compliance Director
Novartis Pharma AG
Embedding a culture of integrity
Key
Speakers
We’re bringing together senior
representatives working in
compliance, legal and transparency
to discuss operational best practices.
These individuals will give you
essential insights so you can bench
mark your strategy, manage future
risk and embed a culture of integrity.
Gain essential insight at Pharma
Compliance Europe, taking place
on the 7-8 October in London.
Your peers will be there networking,
learning and bench marking their
compliance programme. Will you?
5. DAY ONE WEDNESDAY 7TH
OCTOBER 2015
08:50
10:15
10:45
12:45
16:15
16:45
17:45
17:50
13:45
14:15
14:45
15:15
15:45
09:30
11:15
11:45
12:15
Opening remarks from the chair
Speed networking
Morning refreshments
Lunch
Afternoon refreshments
Peer-to-peer roundtables
Closing remarks
Drinks party
PANEL: How to establish a corporate compliant culture and implement an ethical business conduct
Martin Fuerle, Head of Legal and Chief Compliance Officer, Daiichi Sankyo Europe
Elke Baumann, Global Integrity & Compliance Director, Novartis Pharma AG
Dr. Erik Eglite, Vice President, Chief Compliance Officer & Corporate Counsel, Lundbeck
Working with regional offices to develop and implement a compliance programme that works
for your organisation
Stephanie Wingrove, Director, Compliance & Ethics EAME, Allergan
Achieve better compliance culture with a strong “tone in the middle’’ – Compliance Champions Program
Nadia Comanescu, Regional Compliance Lead for E.M.E., Russia, Turkey and India, Pfizer
09:00 Managing compliance risks in a global market by driving better practices, ownership and accountability
Dr. Erik Eglite, Vice President, Chief Compliance Officer & Corporate Counsel, Lundbeck
Transparency landscape in Europe: Implementation of EFPIA in pharma vs. banned direct sponsorship of
HCPs in MedTech
Diva Duong, Vice President Compliance EMEA-APAC, IMS Health
COMPLIANT MARKETING AND SALESTRANSPARENCY AND REPORTING
Transparency: Legislation or self-regulation?
Andrew Powrie-Smith, Communications Director, EFPIA
Transparency current challenges
Marcel Koerting, LL.M., Senior Legal and Compliance
Council, Novo Nordisk
Local perspective: practical approach to aggregate
spend, disclosure and transparency
David Eves, European Head of Compliance, Chugai
Transparency reporting and overcoming the hurdle
of data privacy laws
Holger Diener, Managing Director, Association of voluntary
Self-regulation for the pharmaceutical industry, FSA
Navigating data privacy laws while maintaining
transparency and reporting
Nick Tyler, Senior Director and Global Privacy Officer, Takeda
Pharmaceuticals International GmbH
Optimising your interactions with HCPs through a
fully compliant and transparent strategy
Professor Tim Evans, Editor-in-chief, Royal College of
Physicians
Managing HCP interactions and overcoming
practical challenges
Representative, Veeva Systems
Building a real cross functional, promotional
compliance organisation
Jesper Lund Bredesen, HQ-PARC Chair (MD), Divisional
Director, Medical Affairs & Clinical Dev. Centres, Lundbeck
GSK interactions with HCPs – why, how and what
we’re changing
GSK tentative
Industry sponsorship of medical education and
corruption risks
Michel Ballieu, CEO, European CanCer Organisation
DAY TWO THURSDAY 8TH
OCTOBER 2015
08:50 Opening remarks from the chair - Diva Duong, Vice President Compliance EMEA-APAC, IMS Health
10:30 Morning refreshments
09:00
Embedding a culture of integrity
Elke Baumann, Global Integrity & Compliance Director, Novartis Pharma AG
09:30
Delivering effective training to promote and enforce compliance standards
Aneta Slusarczyk, European Healthcare Compliance Training Officer, Astellas Ltd tentative
10:00
PANEL: Compliance as a profession: capabilities, training and talent management
Peter Herrmann, Corporate Compliance Officer, Actelion
11:00 Accountability and risk of the compliance officer himself
Dr. Christoph C. Dengler, Vice President Legal, Stada
11:30
12:00
Effective anti-bribery and anti-corruption programme management and monitoring to mitigate risk
Ivan Koen, Director Legal & Compliance International, Merck
Effective due diligence processes
Speaker to be confirmed
12:30 Lunch
15:00 Afternoon refreshments
16:30 Close of conference
13:50
PANEL: Internal business ethics controls
Tamara Tubin, Corporate Compliance Director, International, Biogen International GmbH
Natalia Kovaleva, Compliance Officer Russia and CIS, Novo Nordisk
Stephen Nguyen-Duc, Office of Ethics & Compliance Regional Director, International Operations,
Western Europe &Canada, AbbVie tentative
14:30
PANEL: Monitoring and auditing best practices to provide insight into key risk areas and internal controls
Lindsay Beardsworth, Head of Internal Audit, Ferring Pharmaceuticals
Additional speaker to be confirmed
15:30
Unravelling the compliance challenges relating to data privacy and protection in R&D
Anne Bahr, Ph.D, CIPP/E, R&D Privacy Officer, R&D Compliance department, Sanofi
16:00
CRO relations and outsourced clinical trials
Dennis K. Barnes, Vice President, Chief Compliance Officer, PAREXEL International
13:30
Due diligence, monitoring and risk analysis of third parties to identify high risk business transactions
Tamara Tubin, Corporate Compliance Director, International, Biogen International GmbH
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
6. ROUNDTABLES 10 REASONS TO ATTEND
Benchmark your compliance programme and discuss the latest
challenges with industry leaders
1
Learn the latest challenges with disclosure initiatives across
Europe
2
Optimise your compliance programme by working with regional
offices to develop and implement a compliance programme that
works for your organisation
3
Explore current anti-bribery and anti-corruption challenges and
strategies to mitigate risk
4
Share experiences, insights and strategies in interactive peer-to-
peer roundtables
5
Understand internal business ethics controls to identify high risk
business transactions
6
Master consent to disclose and relationships with HCPs7
Unravel the compliance challenges relating to data privacy and
protection
8
Master clinical trials compliance and understand implications of
the new clinical trial regulations
9
Network with pioneers, influencers and innovators and return to
your company with new ideas and relationships
10
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
Peer-to-peer roundtables provide an interactive engaging platform
where compliance and transparency opportunities can be
explored, challenges can be solved and emerging solutions can be
evaluated. Choose the topic relevant to you and join the discussion.
Practical approaches to
transparency
Natalia Kovaleva, Compliance Officer
Russia and CIS, Novo Nordisk
Due diligence and monitoring
for effective third party risk
management
Overcoming issues in running a
global compliance programme
Ian Storey, Senior Director Compliance,
AstraZeneca
Dissemination and exchange
of scientific information – the
line between promotion and
scientific exchange
Kevin Christopher, Promotional Compliance
Manager, Baxter Healthcare Ltd
Anti-bribery and anti-
corruption programme design,
management and monitoring
Managing consent to disclose
and relationships with HCPs
Jörn Johannsen, Head of Compliance
Germany, AbbVie
7. REGISTRATION
7
1
14
12
10
8
6
4
15
13
REFRESH
M
EN
TS
REFRESHMENTS
11
9
5
3
16
2
STORE
ROOM
W.C
W.C COATS
STAIRS
FLOORPLAN
WHY SPONSOR?
The event is a focal meeting point for stakeholders
in the compliance area and will be complemented
by expert speakers across the programme.
If you provide a product or service for compliance
then Pharma Compliance is an event you can’t
afford to miss.
• Get your brand in front of senior decision
makers
• Break into the lucrative compliance market
• Position your company as an industry leader
• Create sales leads and deliver a return on
investment
• Network with your target market in the region
Meeting the right people is key for you,
and we know that, that’s why we focus
on making it happen for you. We bring
you chief compliance officers and senior
compliance, transparency and legal
professionals together. This is where the
compliance community learn from industry
peers who will discuss the best practices
in managing risk. You will have a chance
to network with professionals that are
eager to discover the latest solutions and
services in the market.
Getting involved is easy – give us a call
and tell us how we can help you and we’ll
do our best to meet (and exceed) your
expectations.
Contact Edmond Rama on
+44 0207 092 1052 or
erama@healthnetworkcommunications.com
WHO WILL YOU MEET?
Heads of...
• Compliance
• Ethics
• Legal Affairs
• General Counsel
• Regulatory Affairs
• Medical Directors
• Corruption/Risk
Management
• Corporate Responsibility
• Head of Governance
• IT
• Commercial Operations
Marketing
WHO SHOULD SPONSOR?
Sponsors and exhibitors should include companies
providing the following services:
• Implementation partners and system integrators
• Enterprise software
• Training solutions
• Lawyers
• Consulting
• Event organisers
SOLD
AVAILABLE
FOR MORE INFORMATION ABOUT SPONSORSHIP AND PROMOTIONAL OPPORTUNITIES,
CONTACT EDMOND +44 0207 092 1052 or email erama@healthnetworkcommunications.com
8. NETWORKING
We know the importance of networking and offer an experience which
allows you to do just that. With the bespoke mobile app, dedicated
networking managers and peer-to-peer partnering, we ensure that you
get the most from your time on site.
Innovation and strategy for
pharmaceutical, biotech and R&D
• Plan your sessions
• Build a personalised agenda
• Identify exhibitors to visit
• Set up onsite meetings with key
executives
• Network with other attendees
Use the portal to:
DOWNLOAD OUR NETWORKING APP
Download our networking app to get organised and get in touch with all
attendees before the event.
CONNECT WITH US
@TotalBioPharma #PharmaCompliance
Total BioPharma - Networking for Pharmaceuticals, Biotech and R&D
YOUR NETWORKING MANAGER
Take advantage of this dedicated and personalised meeting
service. Hold meetings with prequalified partners arranged by your
networking manager in your private on-site meeting room. Keep
all your messages, appointments and favourites at your fingertips
and continue networking whilst you’re there. You can still use the
networking tool within the app for a full year after the event so you can
follow up with anybody you’ve missed months down the line.
BIANCA GELDENHUYS
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance
9. RESERVE YOUR PLACE TODAY
The earlier you book the more you’ll save.
It’s really easy to register online.
And our online calculator will ensure you take advantage
of the best deal.
Go to and register
www.healthnetworkcommunications.com/compliance
BOOK NOW
Go to www.healthnetworkcommunications.com/compliance
and register with a special discount code BR04
Or call +44 (0) 207 092 1210
BOOKING CODE
Package
2 day conference
Final price
£1,395
BR04
Register now and get the offer price - on your phone
Scan this QR pattern with the camera on your smartphone and register with
a discount code BR04 at the special offer price.
Don’t have a QR reader app? You can download one for free from App Store.
Don’t have a smartphone? You can also register and get the offer on our website
www.healthnetworkcommunications.com/compliance
BOOK ONLINE NOW AT
www.healthnetworkcommunications.com/compliance